Choice of anesthesia could impact breast cancer metastasis, according to a new study led by Stony Brook University Cancer Center researchers and published in Nature Communications.
Jun Lin, MD, PhD,
Jun Lin, MD, PhD, Department of Anesthesiology in the Renaissance School of Medicine at Stony Brook University, and colleagues found that sevoflurane anesthesia leads to more metastatic burden in the lung after breast tumor resecting surgery than propofol in laboratory models.
The study findings may serve as a guide to design clinical trials for clinicians to optimize anesthesia choice for breast cancer surgery in order to achieve best long-term outcomes.
Dr. Lin’s research is supported by the New York State Department of Health’s Peter J. Rowley Breast Cancer Scientific Research Project, the Renaissance School of Medicine’s Targeted Research Opportunity “Walk for Beauty” grant, and from the Department of Anesthesiology’s Research Fund.
Stony Brook Brings AI Expertise to Long Island Small Businesses Through LIA-AI Growth Academy
Lav Varshney Discusses AI and the Physical Economy of Intelligence
Two URECA Students Explore Real-World Ideas Through Research
Stony Brook Researchers Develop a Blueprint for Self-Improving AI
